Current evidence suggests that BPC-157 is not a weight loss peptide and does not directly burn fat, suppress appetite, or significantly increase metabolism
However, human evidence remains limited , and BPC-157 is not FDA-approved for clinical use
Beyond that landmark study, the evidence base includes research showing GHK-Cu enlarges hair follicle size, extends the anagen (active growth) phase, stimulates dermal papilla cells (the cells that control follicle activity), promotes angiogenesis (blood vessel growth) to the scalp, and reduces the DHT-related inflammation that causes follicle miniaturization in androgenetic alopecia
Also improved my sleep and mood
Additional controlled human research in individuals with sleep disturbances suggests that DSIP can normalize disrupted sleep patterns, extending periods of sleep with fewer awakenings and improved overall quality